Clinical trial
Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
NCT00485134 is registered in ClinicalTrials.gov with U.S. Army Medical Research and Development Command as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection
- Lead sponsor
- U.S. Army Medical Research and Development Command
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- September 30, 2010
- Enrollment
- 113 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
shigellosis